Odyssey Health, Inc. (ODYY) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US67612C1027
Odyssey Health, Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -1.02 m USD | -912,994.00 USD |
| EBIT | -1.49 m USD | -4.15 m USD |
| Net income | -1.74 m USD | -5.73 m USD |
| Diluted EPS – continuing operations | -0.02 USD | -0.05 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Odyssey Health, Inc.
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.
More stocks
- ORAGENICS INC (OGEN)
- Kaya Holdings, Inc. (KAYS)
- Adagio Medical Holdings, Inc. (ADGM)
- GPO Plus, Inc. (GPOX)
- Ocean Thermal Energy Corp (CPWR)
- Sirius Media (ALSRS.PA)
- AVENUE THERAPEUTICS, INC. (ATXI)
- Catheter Precision, Inc. (VTAK)
- Lunai Bioworks Inc. (LNAI)
- Mentor Capital, Inc. (MNTR)
- ProtoKinetix, Inc. (PKTX)
- Athena Bitcoin Global (ABIT)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.